Trial Profile
Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine With the Omission of Immune Globulin to Prevent Hepatitis B Transmission in Mother With High Viral Load: A Multi-Center, Prospective, Randomized and Open-Label Study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Dec 2022
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Hepatitis B immune globulin; Hepatitis B vaccine
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors New Discovery
- 08 Nov 2022 Results of safety NCT03476083 and other studies ,presented at The Liver Meeting 2022: 73rd Annual Meeting of the American Association for the Study of Liver Diseases
- 10 Dec 2019 Planned End Date changed from 1 May 2022 to 1 May 2024.
- 10 Dec 2019 Planned primary completion date changed from 1 May 2020 to 1 May 2021.